In a study of men on active surveillance for low-risk prostate cancer, multiparametric magnetic resonance imaging by itself missed about one-fifth of men who had pathologic upgrading on subsequent biopsies.
Confirmatory biopsy with MRI guidance provides a more accurate risk assessment than a conventional transrectal ultrasound confirmatory biopsy, according to researchers.
Low-dose whole-body CT recommended over conventional skeletal survey for detection of bone disease.
In a head-to-head comparative study involving PCa patients with early biochemical recurrence following radical surgery, PSMA PET/CT had significantly higher cancer detection rates than fluciclovine PET/CT.
A retrospective, observational study investigated the impact of obtaining a second opinion of a breast cancer diagnosis from a multidisciplinary tumor board.
A study presented at 2018 ASCO Quality Care Symposium demonstrates further support for Choosing Wisely Initiative’s recommendations against routine scanning in early-stage breast cancer.
Four of 9 lung cancer screening models were shown to effectively select the most appropriate candidates for low-dose CT lung cancer screening among US ever-smokers.
A sizable number of breast cancer survivors do not undergo annual surveillance.
A study presented at the 2018 ONS Annual Congress explored the feasibility of an advanced practice nurse-led lung cancer screening program at ambulatory outpatient clinics.
A review of surveillance mammography demonstrated the potential value of these images in post primary therapy treatment of women with breast cancer.
